Celldex Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $25.2M | $444.7M | $39.1M |
| FY2022 | $26.5M | $352.7M | $29.4M |
| FY2023 | $36.5M | $465.6M | $34.8M |
| FY2024 | $45.3M | $792.3M | $28.4M |
| FY2025 | $55.8M | $583.0M | $28.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $25.2M | $444.7M | $39.1M |
| FY2022 | $26.5M | $352.7M | $29.4M |
| FY2023 | $36.5M | $465.6M | $34.8M |
| FY2024 | $45.3M | $792.3M | $28.4M |
| FY2025 | $55.8M | $583.0M | $28.9M |